Clinical trials
Phase 1 Squamous Cell Carcinoma of Head and Neck trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
443 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 7 |
| 2002 | 4 |
| 2003 | 3 |
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 9 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 14 |
| 2014 | 13 |
| 2015 | 25 |
| 2016 | 16 |
| 2017 | 24 |
| 2018 | 30 |
| 2019 | 28 |
| 2020 | 37 |
| 2021 | 25 |
| 2022 | 27 |
| 2023 | 37 |
| 2024 | 32 |
| 2025 | 31 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 189 |
| Terminated | 85 |
| Recruiting | 77 |
| Active, not recruiting | 41 |
| Withdrawn | 23 |
| Unknown status | 14 |
| Not yet recruiting | 13 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 25 |
| AbbVie | 13 |
| Pfizer | 11 |
| M.D. Anderson Cancer Center | 9 |
| Vanderbilt-Ingram Cancer Center | 8 |
| Dana-Farber Cancer Institute | 7 |
| Presage Biosciences | 7 |
| AstraZeneca | 6 |
| Case Comprehensive Cancer Center | 6 |
| Novartis Pharmaceuticals | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 443 |
| Carcinoma, Non-Small-Cell Lung | 157 |
| Head and Neck Neoplasms | 103 |
| Melanoma | 91 |
| Colorectal Neoplasms | 82 |
| Carcinoma, Renal Cell | 69 |
| Ovarian Neoplasms | 61 |
| Breast Neoplasms | 60 |
| Stomach Neoplasms | 60 |
| Triple Negative Breast Neoplasms | 58 |
Trials
Showing 1 to 25 of 443. Each trial links to its page on Pharma Observatory.
343 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.